Top2b regulates morphological and migratory properties of retinal progenitor cells in vivo and upon transplantable matrix substrates
Exploration of BioMat-X · 2025
DOI: 10.37349/ebmx.2025.101335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exploration of BioMat-X, 2025. Verfasst von Alexandra C Dabrowski und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Rutgers, The State University of New Jersey-New Brunswick, Piscataway, NJ 08854, US. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Aim
This study evaluated the impact of retinal extracellular matrix (ECM) and key biomaterial substrates on the motility of transplantable retinal cells with genomic manipulation, using the therapeutic molecule, Topoisomerase II beta (Top2b), as a model.
Methods
Tests first applied in ovo electroporation to examine the effects of a pharmacological Top2b inhibitor (ICRF-193) on progenitor motility and development of embryonic retina. Complementary qRT-PCR tests measured changes in select cadherin molecules in response to treatment. In vitro transfection produced cultured retinal progenitor cell groups with Top2b overexpression and Top2b knockdown. Differences in the adhesion and motility of Top2b altered groups, compared to wildtype cells, were measured upon biomaterial substrates used in emerging transplantation matrixes.
Results
Data illustrated significant differences in the number and spacing of retinal ganglion cells when retina was treated with ICRF-193, as well as downregulation of several key cadherin molecules. Cultured retinal progenitors with Top2b knockdown and Top2b overexpression exhibited different expression of chemotactic receptors, adhesion parameters, and modalities of migration upon substrates of laminin, poly-L-lysine, and collagen IV. Significant changes in cell morphology and surface area were also measured compared to wildtype cells.
Conclusions
Corroborating in vivo and in vitro data support Top2b as a therapeutic target for retinal progenitor motility but indicate significant differences in the migration of Top2b altered cells upon substrates used in transplantation. These data highlight the therapeutic advantages of bioinspired materials developed to aid the motility of replacement cells with modified genetic expression to improve transplantation outcomes across the nervous system.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Rutgers, The State University of New Jersey-New Brunswick, Piscataway, NJ 08854, US.
ORCID-Profile: Alexandra C Dabrowski, Alexandria R Logan, Brianna Rodriguez, Li Cai, Maribel Vazquez
Förderung
- NEI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Dabrowski, A. C., Logan, A. R., Rayaji, R., Rodriguez, B., Cai, L., & Vazquez, M. (2025). Top2b regulates morphological and migratory properties of retinal progenitor cells in vivo and upon transplantable matrix substrates. Exploration of BioMat-X. https://doi.org/10.37349/ebmx.2025.101335
Vancouver
Dabrowski AC, Logan AR, Rayaji R, Rodriguez B, Cai L, Vazquez M. Top2b regulates morphological and migratory properties of retinal progenitor cells in vivo and upon transplantable matrix substrates. Exploration of BioMat-X. 2025. doi:10.37349/ebmx.2025.101335
BibTeX
@article{Dabrowski2025,
author = {Dabrowski, Alexandra C and Logan, Alexandria R and Rayaji, Rameshwari and Rodriguez, Brianna and Cai, Li and Vazquez, Maribel},
title = {Top2b regulates morphological and migratory properties of retinal progenitor cells in vivo and upon transplantable matrix substrates},
journal = {Exploration of BioMat-X},
year = {2025},
doi = {10.37349/ebmx.2025.101335}
}
EUVIMED